Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors

NCT00108069 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

43

Enrollment

NIH

Sponsor class

Conditions

Glioma

Interventions

DRUG: Tamoxifen citrate
DRUG: Bortezomib

Sponsor

National Cancer Institute (NCI)